Geneva Biotech is a privately held biotechnology company, based in Geneva, Switzerland. Founded in 2012

Pipeline

Focus on COVID-19

Welcome Guest \\ Login

Pipeline

OUR PIPELINE & SCIENCE

Led by scientists with an elite level track record in biomedical research, we are advancing a pipeline of novel and proprietary drug candidates by applying our unique platform technologies.

Pipeline Development Programs

IP POSITION

6 patent families covering:

  • Material composition on small molecule drug candidates
  • Methods and material composition on small molecule drug combination therapies
  • Material composition and methods for SARS-CoV-2 Spike protein with linoleic acid, mimetics or derivatives for multiple fields of use in small molecule discovery, antibody discovery, or diagnostics development
  • Drug discovery methods targeting the SARS-CoV-2 Spike protein linoleic acid binding pocket, including for fatty acid mimetics or derivatives

INVESTMENT, LICENSING, AND PARTNERING

Please contact us for partnering, licensing, or investment opportunities

Research Highlights

our r&d View all

Latest News

GENEVA BIOTECH CO-FOUNDERS PUBLISH IN SCIENCE GOOD REVIEW IN FORBES Geneva Biotech co-founders publish in Science good review in Forbes ...

View all

Contact Us